OCUL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $7,024,764.52

Insider Selling (Last 12 Months): $198,963.46

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$5.93

▲ +0.13 (2.24%)

As of 05/7/2024 01:00 AM ET

Days: 30 | 90 | 365

AI “wealth window” is closing June 25th

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/26/2024	Summer Road Llc	Major Shareholder	Buy	930,851	$7.52	$6,999,999.52	8,591,401
1/31/2024	Antony C. Mattessich	CEO	Sell	18,338	$4.95	$90,773.10	427,943
1/31/2024	Donald Notman	CFO	Sell	6,433	$4.95	$31,843.35	139,932
1/31/2024	Philip C Strassburger	General Counsel	Sell	6,831	$4.95	$33,813.45	109,218
1/31/2024	Rabia Gurses Ozden	Insider	Sell	7,764	$4.95	$38,431.80	92,767
8/30/2023	Antony C. Mattessich	CEO	Buy	6,500	$3.81	$24,765.00	6,500
7/7/2023	Rabia Gurses Ozden	Insider	Sell	832	$4.93	$4,101.76	100,531
2/6/2023	Antony C. Mattessich	CEO	Sell	19,669	$4.24	$83,396.56	446,281
2/6/2023	Christopher G White	Insider	Sell	5,829	$4.24	$24,714.96	94,766
2/6/2023	Donald Notman	CFO	Sell	6,476	$4.24	$27,458.24	139,387
2/6/2023	Philip C Strassburger	General Counsel	Sell	6,181	$4.24	$26,207.44	109,071
11/7/2022	Summer Road Llc	Major Shareholder	Buy	7,328	$3.50	$25,648.00	6,122,089
10/10/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.00	$40,000.00	6,104,761
9/29/2022	Summer Road Llc	Major Shareholder	Buy	18,800	$4.04	$75,952.00	6,094,761
9/27/2022	Summer Road Llc	Major Shareholder	Buy	130,000	$4.68	$608,400.00	6,074,761
2/23/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.80	$48,000.00
2/18/2022	Summer Road Llc	Major Shareholder	Buy	40,000	$5.00	$200,000.00
1/27/2022	Summer Road Llc	Major Shareholder	Buy	1,477	$5.20	$7,680.40
1/24/2022	Summer Road Llc	Major Shareholder	Buy	44,400	$5.31	$235,764.00
1/20/2022	Summer Road Llc	Major Shareholder	Buy	17,948	$5.70	$102,303.60
1/18/2022	Summer Road Llc	Major Shareholder	Buy	6,807	$6.00	$40,842.00
1/13/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$6.20	$62,000.00
12/15/2021	Summer Road Llc	Major Shareholder	Buy	15,000	$6.22	$93,300.00
12/13/2021	Summer Road Llc	Major Shareholder	Buy	10,510	$6.50	$68,315.00
12/10/2021	Summer Road Llc	Major Shareholder	Buy	30,000	$6.65	$199,500.00
12/8/2021	Summer Road Llc	Major Shareholder	Buy	5,300	$6.75	$35,775.00
12/6/2021	Summer Road Llc	Major Shareholder	Buy	55,600	$6.13	$340,828.00
8/20/2021	Antony C. Mattessich	CEO	Buy	5,000	$9.89	$49,450.00	102,900
5/20/2021	Richard L. Lindstrom	Director	Sell	10,000	$14.30	$143,000.00	90,000

AI “wealth window” is closing June 25th

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

59.21% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2024	SG Americas Securities LLC	28,946	$0.26M	0.0%	+47.3%	0.019%
5/6/2024	Quantbot Technologies LP	46,500	$0.42M	0.0%	N/A	0.030%
5/3/2024	Essex Investment Management Co. LLC	376,200	$3.42M	0.7%	+1.6%	0.243%
5/1/2024	BNP Paribas Financial Markets	185,308	$1.69M	0.0%	+373.1%	0.120%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	53,456	$0.49M	0.0%	N/A	0.035%
4/29/2024	Principal Financial Group Inc.	27,880	$0.25M	0.0%	+27.0%	0.018%
4/29/2024	China Universal Asset Management Co. Ltd.	21,199	$0.19M	0.0%	+130.6%	0.014%
4/24/2024	Simplicity Wealth LLC	28,987	$0.26M	0.0%	N/A	0.019%
4/17/2024	Deltec Asset Management LLC	2,364,084	$21.51M	4.2%	-3.3%	1.591%
3/8/2024	Trust Co. of Vermont	6,000	$27K	0.0%	+20.0%	0.008%
2/26/2024	Virtu Financial LLC	62,066	$0.28M	0.0%	N/A	0.078%
2/15/2024	Opaleye Management Inc.	6,070,000	$27.07M	7.3%	-6.2%	7.643%
2/15/2024	Great Point Partners LLC	700,000	$3.12M	0.5%	N/A	0.881%
2/14/2024	Artia Global Partners LP	440,000	$1.96M	0.6%	N/A	0.554%
2/13/2024	Aristides Capital LLC	50,226	$0.22M	0.1%	N/A	0.063%
2/13/2024	Tower Research Capital LLC TRC	9,756	$44K	0.0%	+142.3%	0.012%
2/9/2024	Franklin Resources Inc.	4,500,159	$20.07M	0.0%	N/A	5.666%
2/8/2024	Essex Investment Management Co. LLC	370,372	$1.65M	0.3%	N/A	0.466%
2/7/2024	Ieq Capital LLC	30,129	$0.13M	0.0%	-64.4%	0.038%
2/5/2024	Victory Capital Management Inc.	10,135	$45K	0.0%	N/A	0.013%
1/29/2024	Simplicity Solutions LLC	44,987	$0.20M	0.0%	N/A	0.057%
1/24/2024	China Universal Asset Management Co. Ltd.	9,192	$41K	0.0%	+350.6%	0.012%
1/22/2024	Deltec Asset Management LLC	2,443,607	$10.90M	2.5%	+18.5%	3.077%
1/18/2024	Relyea Zuckerberg Hanson LLC	17,600	$78K	0.0%	N/A	0.022%
1/16/2024	Raymond James Financial Services Advisors Inc.	62,040	$0.28M	0.0%	-16.6%	0.078%
1/16/2024	Raymond James & Associates	129,012	$0.58M	0.0%	+7.0%	0.162%
1/16/2024	Legato Capital Management LLC	149,515	$0.67M	0.1%	N/A	0.188%
1/12/2024	SG Americas Securities LLC	19,646	$88K	0.0%	+60.5%	0.025%
12/6/2023	Citigroup Inc.	20,132	$63K	0.0%	-44.3%	0.025%
11/22/2023	Graham Capital Management L.P.	95,363	$0.30M	0.0%	N/A	0.120%
11/15/2023	GSA Capital Partners LLP	233,582	$0.73M	0.1%	+96.4%	0.294%
11/15/2023	Sectoral Asset Management Inc.	969,350	$3.04M	0.6%	+20.8%	1.221%
11/14/2023	Profund Advisors LLC	20,827	$65K	0.0%	+94.1%	0.026%
11/13/2023	Algert Global LLC	25,480	$80K	0.0%	-48.2%	0.032%
11/13/2023	Paradigm Capital Management Inc. NY	80,000	$0.25M	0.0%	+100.0%	0.101%
11/13/2023	Rafferty Asset Management LLC	11,837	$37K	0.0%	N/A	0.015%
11/7/2023	New York State Common Retirement Fund	31,521	$99K	0.0%	+229.0%	0.040%
11/7/2023	Barclays PLC	25,963	$81K	0.0%	+22.9%	0.033%
10/31/2023	Levin Capital Strategies L.P.	22,500	$71K	0.0%	-30.8%	0.028%
10/26/2023	Emerald Advisers LLC	20,768	$65K	0.0%	-54.6%	0.026%
10/24/2023	Bank of New York Mellon Corp	240,310	$0.76M	0.0%	-18.1%	0.303%
10/24/2023	Raymond James Financial Services Advisors Inc.	74,401	$0.23M	0.0%	+46.6%	0.094%
10/24/2023	Raymond James & Associates	120,561	$0.38M	0.0%	+155.2%	0.152%
10/23/2023	Deltec Asset Management LLC	2,061,797	$6.47M	1.5%	+4.4%	2.597%
10/13/2023	SG Americas Securities LLC	12,242	$38K	0.0%	N/A	0.015%
9/21/2023	Barclays PLC	21,123	$0.11M	0.0%	-92.4%	0.027%
8/17/2023	Coastal Bridge Advisors LLC	10,900	$56K	0.0%	N/A	0.014%
8/14/2023	Cormorant Asset Management LP	645,000	$3.33M	0.2%	N/A	0.812%
8/11/2023	Harvest Investment Services LLC	61,960	$0.32M	0.2%	N/A	0.078%
8/11/2023	Sectoral Asset Management Inc.	802,680	$4.14M	0.7%	N/A	1.011%
8/10/2023	Profund Advisors LLC	10,728	$55K	0.0%	N/A	0.014%
8/7/2023	Lincoln National Corp	57,226	$0.30M	0.0%	N/A	0.074%
8/3/2023	Mackenzie Financial Corp	44,173	$0.22M	0.0%	-33.0%	0.057%
8/2/2023	Bank of Montreal Can	181,509	$0.94M	0.0%	N/A	0.234%
7/31/2023	Levin Capital Strategies L.P.	32,500	$0.17M	0.0%	-84.3%	0.042%
7/31/2023	Strs Ohio	38,200	$0.20M	0.0%	-34.0%	0.049%
7/28/2023	Carson Advisory Inc.	11,852	$0.70M	0.4%	N/A	0.015%
7/27/2023	Virtu Financial LLC	13,383	$69K	0.0%	N/A	0.017%
7/27/2023	Carson Advisory Inc.	11,852	$0.70M	0.6%	N/A	0.015%
7/25/2023	Raymond James Financial Services Advisors Inc.	50,764	$0.26M	0.0%	+244.0%	0.065%
7/25/2023	DekaBank Deutsche Girozentrale	100,000	$0.51M	0.0%	+300.0%	0.129%
7/24/2023	Allspring Global Investments Holdings LLC	15,803	$82K	0.0%	+366.2%	0.020%
7/24/2023	Vontobel Holding Ltd.	10,000	$52K	0.0%	-60.0%	0.013%
7/19/2023	Daymark Wealth Partners LLC	25,000	$0.13M	0.0%	N/A	0.032%
7/18/2023	Deltec Asset Management LLC	1,974,797	$10.19M	2.2%	+3.2%	2.547%
7/18/2023	Allspring Global Investments Holdings LLC	15,803	$82K	0.0%	+366.2%	0.020%
5/12/2023	Aristides Capital LLC	35,000	$0.18M	0.1%	N/A	0.045%
5/12/2023	Tejara Capital Ltd	72,457	$0.38M	0.2%	-29.3%	0.093%
5/10/2023	Banco Santander S.A.	267,889	$1.41M	0.0%	-18.4%	0.346%
5/4/2023	Barclays PLC	279,687	$1.47M	0.0%	-12.3%	0.361%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	52,084	$0.27M	0.0%	N/A	0.067%
5/4/2023	Emerald Advisers LLC	45,717	$0.24M	0.0%	-95.3%	0.059%
5/3/2023	Jump Financial LLC	112,000	$0.59M	0.0%	N/A	0.144%
5/2/2023	Ieq Capital LLC	84,529	$0.45M	0.0%	-39.4%	0.109%
4/28/2023	SG Americas Securities LLC	33,849	$0.18M	0.0%	N/A	0.044%
4/27/2023	Strs Ohio	57,900	$0.31M	0.0%	+264.2%	0.075%
4/24/2023	Mackenzie Financial Corp	65,973	$0.35M	0.0%	N/A	0.085%
4/24/2023	Levin Capital Strategies L.P.	207,624	$1.09M	0.1%	-23.3%	0.268%
4/24/2023	DekaBank Deutsche Girozentrale	25,000	$0.14M	0.0%	N/A	0.032%
4/24/2023	Ahrens Investment Partners LLC	8,000	$42K	0.0%	N/A	0.010%
4/18/2023	Archford Capital Strategies LLC	20,000	$98K	0.0%	N/A	0.026%
4/17/2023	Deltec Asset Management LLC	1,913,612	$10.09M	2.5%	+3.3%	2.469%
4/14/2023	Raymond James & Associates	49,057	$0.26M	0.0%	+27.5%	0.063%
3/23/2023	MetLife Investment Management LLC	26,871	$76K	0.0%	-34.3%	0.035%
2/13/2023	Levin Capital Strategies L.P.	270,692	$0.76M	0.1%	-25.6%	0.352%
2/10/2023	Opaleye Management Inc.	6,075,000	$17.07M	5.9%	-6.0%	7.889%
2/8/2023	Belpointe Asset Management LLC	12,550	$35K	0.0%	N/A	0.016%
2/8/2023	Russell Investments Group Ltd.	13,561	$38K	0.0%	-56.2%	0.018%
2/6/2023	Ieq Capital LLC	139,529	$0.39M	0.0%	-50.9%	0.181%
2/3/2023	Emerald Mutual Fund Advisers Trust	680,588	$1.91M	0.1%	-37.1%	0.884%
2/3/2023	Emerald Advisers LLC	965,241	$2.71M	0.1%	-35.9%	1.253%
1/25/2023	Deltec Asset Management LLC	1,852,945	$5.21M	1.5%	-20.3%	2.406%
11/15/2022	Endurant Capital Management LP	1,064,295	$4.42M	1.4%	+40.0%	1.382%
11/15/2022	Federated Hermes Inc.	801,736	$3.33M	0.0%	-32.7%	1.041%
11/14/2022	Tudor Investment Corp Et Al	61,775	$0.26M	0.0%	+21.0%	0.080%
11/14/2022	Boothbay Fund Management LLC	47,381	$0.20M	0.0%	N/A	0.062%
11/14/2022	Ergoteles LLC	119,265	$0.50M	0.0%	N/A	0.155%
11/14/2022	Altium Capital Management LP	517,133	$2.15M	0.8%	-25.6%	0.672%
11/14/2022	UBS Oconnor LLC	223,066	$0.93M	0.0%	-56.5%	0.290%
11/10/2022	ExodusPoint Capital Management LP	13,402	$56K	0.0%	N/A	0.017%

Data available starting January 2016

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $5.93

$5.67

$6.07

50 Day Range

MA: $8.10

$4.20

$10.93

52 Week Range

Now: $5.93

$2.00

$11.31

Volume

2,432,707 shs

Average Volume

2,320,170 shs

Market Capitalization

$917.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Ocular Therapeutix?: Ocular Therapeutix's top insider investors include:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Christopher G White (Insider)
Learn More about top insider investors at Ocular Therapeutix.
Who are the major institutional investors of Ocular Therapeutix?: Ocular Therapeutix's top institutional investors include:
Deltec Asset Management LLC — 1.59%
Essex Investment Management Co. LLC — 0.24%
BNP Paribas Financial Markets — 0.12%
Mirae Asset Global Investments Co. Ltd. — 0.03%
Quantbot Technologies LP — 0.03%
Simplicity Wealth LLC — 0.02%
Learn More about top institutional investors of Ocular Therapeutix stock.
Which major investors are selling Ocular Therapeutix stock?: In the previous quarter, OCUL stock was sold by these institutional investors:
Deltec Asset Management LLC
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Learn More investors selling Ocular Therapeutix stock.
Which major investors are buying Ocular Therapeutix stock?: During the previous quarter, OCUL stock was acquired by institutional investors including:
BNP Paribas Financial Markets
Mirae Asset Global Investments Co. Ltd.
Quantbot Technologies LP
Simplicity Wealth LLC
China Universal Asset Management Co. Ltd.
SG Americas Securities LLC
Principal Financial Group Inc.
Essex Investment Management Co. LLC
During the previous year, these company insiders have bought Ocular Therapeutix stock:
Summer Road Llc (Major Shareholder)
Antony C Mattessich (CEO)
Learn More investors buying Ocular Therapeutix stock.